Clinical Trial Update: Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating responsiveness to platelet inhibition in patients on chronic antiplatelet therapy for acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: LMU Klinikum | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED